Cleveland Clinic Cancer Advances

Cleveland Clinic Akron General oncologic surgeon, Anthony Visioni, MD, joins the Cancer Advances podcast to discuss the latest trends in melanoma care. Listen as Dr. Visioni highlights the importance of a multidisciplinary team and how recent clinical trials have caused a paradigm shift in melanoma care.

Christopher Weight, MD, Center Director of Urologic Oncology at Cleveland Clinic joins the Cancer Advances podcast to discuss how high-intensity focused ultrasound (HIFU), a type of focal therapy for treating localized prostate cancer, is emerging as an alternative to more traditional treatments, such as surgery and radiation for select patients. Listen as Dr. Weight explains how improved HIFU tec...

Betty Hamilton, MD, Associate Director of the Blood and Marrow Transplant (BMT) Program at Cleveland Clinic joins the Cancer Advances podcast to talk about managing chimeric antigen receptor (CAR) T-cell therapy and other novel cellular therapies within different cancer programs to support participation in and expansion of new clinical trials.

Cleveland Clinic is the first hospital in the world to use an FDA-approved ablation technology that can destroy large liver tumors. Director of Cleveland Clinic's Surgical Liver Ablation Program, Eren Berber, MD, joins the Cancer Advances podcast to discuss how the latest technology allows us to treat larger liver tumors more confidently.

Oncoplastic surgery, which combines lumpectomy with reconstructive surgery, is an option for an increasing number of breast cancer patients. Vice-Chairman of the Department of Plastic Surgery at Cleveland Clinic, Risal Djohan, MD, joins the Cancer Advances podcast to discuss the latest techniques in oncoplastic surgery and which patients make ideal candidates.

Director of Strategic Growth for Cleveland Clinic Cancer Center, Shannon Faulhaber, joins the Cancer Advances podcast to talk about the Cancer Affiliate program. Listen as Shannon highlights what it means to be an affiliate of Cleveland Clinic Cancer Center and how your patients and organization can benefit.

Ehsan Balagamwala, MD, radiation oncologist at Cleveland Clinic Cancer Center, joins the Cancer Advances podcast to talk about stereotactic body radiation therapy (SBRT) for oligometastatic disease. Listen as Dr. Balagmwala highlights how we are pushing the boundaries with SBRT clinical trials, the benefits, and how you can refer a patient.

Onco-nephrology is a nascent field. Nephrologist Roman Shingarev, MD, joins the Cancer Advances podcast to discuss Cleveland Clinic's new onco-nephrology program. Listen as Dr. Shingarev talks about the patients he treats, the program he is building, and what’s ahead in this growing field.

Michael Valente, DO, FACS, FASCRS, Associate Professor of Surgery and Program Director of Cleveland Clinic's Colorectal Surgery Residency Program, joins the Cancer Advances podcast to highlight some of the different strategies for treating peritoneal malignancies, including HIPEC. Listen to learn how treatments have evolved and which patients might be good candidates.

Steven Campbell, MD, PhD, urologic surgeon, and member of the Section of Urologic Oncology in Cleveland Clinic’s Glickman Urological and Kidney Institute, joins the Cancer Advances podcast to discuss the longstanding controversy between partial nephrectomy vs. radical nephrectomy. Listen as Dr. Campbell highlights the possible advantages and disadvantages of each approach and how to know which is...

Director of Laparoscopic Liver Surgery, Choon Hyuck David Kwon, MD, PhD, joins the Cancer Advances podcast to discuss some of the recent advances in laparoscopic liver surgery for liver cancer. Listen as Dr. Kwon highlights new approaches and how having a well-established tumor board and multidisciplinary team can yield better results.

Cleveland Clinic Akron General plastic surgeon, Sarah Bishop, MD, joins the Cancer Advances podcast to talk about some of the recent advances in breast cancer reconstruction. Listen as Dr. Bishop covers some of the different reconstructive techniques, which patients are the best candidates and when is the best timing for patients to undergo breast reconstruction.

Michael Fritz, MD, the Director of the Section of Facial Plastic and Microvascular Surgery, joins the Cancer Advances podcast to discuss salvage operations to improve complications or dysfunction related to prior cancer treatment. Listen as Dr. Fritz highlights different techniques used for salvage surgery and how they have evolved over time.

Pediatric Hematologist-Oncologist at Cleveland Clinic Children's, Peter Anderson, MD, joins the Cancer Advances podcast to talk about the challenges and areas of opportunity in pediatric sarcoma care. Listen as Dr. Anderson covers the importance of multidisciplinary care when managing pediatric sarcoma patients and how virtual visits have become more important than ever.

Chair of the Head and Neck Institute at Cleveland Clinic, Patrick Byrne, MD, MBA, joins the Cancer Advances podcast to discuss novel strategies for facial reconstruction after cancer extirpation. He touches on how facial reconstruction techniques have evolved over the past decade resulting in lower complication rates and how the multidisciplinary team works together for better outcomes.

Jaroslaw Maciejewski, MD, PhD, Chair of the Department of Translational Hematology and Oncology Research and Co-Director of the Bone Marrow Failure and Cytopenias Program, joins the Cancer Advances podcast to discuss these rare conditions. Listen as Dr. Maciejewski highlights how the Bone Marrow Failure and Cytopenias program initially started, what patients might benefit and how physicians can ma...

Emre Gorgun, MD, colorectal surgeon and co-director of Cleveland Clinics Endoluminal Surgery Center, joins the Cancer Advances podcast to discuss the center and management of lesions in the lower GI tract. Listen as Dr. Gorgun explains our approach to resecting lower GI polyps and how this allows patients to avoid surgery, keep their native organs and have an improved quality of life.

Gastroenterologist, advanced endoscopist, and co-director of Cleveland Clinic's Endoluminal Surgery Center, Amit Bhatt, MD, joins the Cancer Advances podcast to discuss the center and management of lesions in the upper GI tract. Listen as Dr. Bhatt gives insight on why the center was initially created, how it has evolved and its benefits for patients.

Eric Klein, MD, Chairman of Cleveland Clinic’s Glickman Urological & Kidney Institute joins the Cancer Advances podcast to discuss how we are leading the way in prostate cancer care. Listen as Dr. Klein highlights the four areas of innovation that are transforming the treatment of prostate cancer and providing individualized, high-quality care for our patients.

In order to bring novel, more effective therapies to the youngest patients, Cleveland Clinic launched a new, early phase clinical trial program called Cleveland Clinic Children’s Cancer Innovative Therapy Program, led by Matteo Trucco, MD, a pediatric hematologist oncologist at Cleveland Clinic Children’s. Dr. Trucco joins the Cancer Advances podcast to talk about the program and how it's bri...

Eric Lamarre, MD, Interim Section Head of Head and Neck Surgery and Oncology with Cleveland Clinic’s Head & Neck Institute, joins the Cancer Advances podcast to talk about HPV-related head and neck cancers. Listen as Dr. Lamarre discusses the shift in demographics for patients with virally related head and neck cancers and the evolution of treatment options.

Sarah Vij, MD, Director of the Center for Male Fertility at Cleveland Clinic, joins the Cancer Advances podcast to discuss Cleveland Clinic's Fertility Preservation Program for Male Cancer Patients. Listen as Dr. Vij discusses the different fertility-sparing techniques used for both pre-pubertal and post-pubertal male cancer patients.

Chair of Subspecialty Care for Women's Health at Cleveland Clinic, Laura Detti, MD, joins the Cancer Advances podcast to discuss Cleveland Clinic's Fertility Preservation Program for Female Cancer Patients. Listen as Dr. Detti highlights the different fertility-sparing techniques used for female cancer patients and the many factors that determine the best option for each patient.

Compared to younger children, cancer rates are higher in adolescents and young adults (AYA). However, AYA's are less likely to receive a prompt diagnosis or be enrolled in clinical trials for innovative treatment. Cleveland Clinic Children's pediatric hematologist oncologist, Stefanie Thomas, MD, joins the Cancer Advances podcast to discuss Cleveland Clinic Children's Adolescent and...

Graham Schwarz, MD, FACS, Director of the Cleveland Clinic Microsurgery and Breast Reconstruction Fellowship and Co-Director of the Multidisciplinary Center for Lymphedema Care, joins the Cancer Advances podcast to talk about the latest in lymphedema. Listen as Dr. Schwarz discusses the Multidisciplinary Lymphedema Center and how patients can benefit, along with the big impact microsurgery and sup...